Researchers successfully used a protein called parapinopsin to turn off brain circuits. This protein is found in lamprey – an ancient lineage of jawless fish similar to eel. Researchers said the ability to inhibit neurons could eventually lead to turning off mood disorders and unwanted behaviors like depression and addiction.
Category: From Newswise – Addiction
New study examines neighborhood and social network’s relation to binge drinking among adults
Study examines how neighborhood and social network characteristics relate to adult binge drinking.
Need to vent? Turn to real-life support, not social media
Social media may make it easier for people to engage online, but I does not provide certain benefits of real-life human interactions, says a Michigan State University researcher.
WashU Expert: FDA menthol ban would benefit Black, younger Americans
The U.S. Food and Drug Administration’s proposed ban on menthol-flavored cigarettes and all flavored cigars could be particularly beneficial for Black and young people, says an expert on tobacco control at Washington University in St. Louis.”Around 80% of adult Black smokers and more than half of people age 18-34 use menthol brands,” said Todd Combs, research assistant professor at the Brown School who works on the Advancing Science & Practice in the Retail Environment (ASPiRE) project, which uses agent-based modeling to test the potential impact of retail tobacco policies.
UC San Diego Researcher Studying Menthol Cigarettes Talks about FDA Ban
Rutgers Experts Available to Discuss Proposed Ban on Menthol Cigarettes and Flavored Cigars
IU researchers tackle the challenges of conducting intrastate policy surveillance
IU researchers tackle the challenges of conducting intrastate policy surveillance and find accessing county and municipal laws challenging in Indiana.
Efforts to reduce opioid prescriptions may be hindering end-of-life pain management
Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.
COVID-19 reduces access to opioid dependency treatment for new patients
COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.
